[go: up one dir, main page]

NO302525B1 - 17-spirofuran-3'-yliden-steroider - Google Patents

17-spirofuran-3'-yliden-steroider Download PDF

Info

Publication number
NO302525B1
NO302525B1 NO924857A NO924857A NO302525B1 NO 302525 B1 NO302525 B1 NO 302525B1 NO 924857 A NO924857 A NO 924857A NO 924857 A NO924857 A NO 924857A NO 302525 B1 NO302525 B1 NO 302525B1
Authority
NO
Norway
Prior art keywords
hydrogen
lower alkyl
spirofuran
ylidene
mixture
Prior art date
Application number
NO924857A
Other languages
English (en)
Norwegian (no)
Other versions
NO924857D0 (no
NO924857L (no
Inventor
Johannes Antonius Mar Hamersma
Everardus Otto Maria Orlemans
Johannes Bernardus Ma Rewinkel
Original Assignee
Akzo Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nv filed Critical Akzo Nv
Publication of NO924857D0 publication Critical patent/NO924857D0/no
Publication of NO924857L publication Critical patent/NO924857L/no
Publication of NO302525B1 publication Critical patent/NO302525B1/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J31/00Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/006Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/24Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/36Antigestagens
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J21/00Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J41/00Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0077Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 substituted in position 11-beta by a carbon atom, further substituted by a group comprising at least one further carbon atom
    • C07J41/0083Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 substituted in position 11-beta by a carbon atom, further substituted by a group comprising at least one further carbon atom substituted in position 11-beta by an optionally substituted phenyl group not further condensed with other rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
NO924857A 1991-12-20 1992-12-15 17-spirofuran-3'-yliden-steroider NO302525B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP91203366 1991-12-20

Publications (3)

Publication Number Publication Date
NO924857D0 NO924857D0 (no) 1992-12-15
NO924857L NO924857L (no) 1993-06-21
NO302525B1 true NO302525B1 (no) 1998-03-16

Family

ID=8208088

Family Applications (1)

Application Number Title Priority Date Filing Date
NO924857A NO302525B1 (no) 1991-12-20 1992-12-15 17-spirofuran-3'-yliden-steroider

Country Status (17)

Country Link
US (1) US5292878A (fi)
EP (1) EP0549041B1 (fi)
JP (1) JP3462515B2 (fi)
KR (1) KR100287513B1 (fi)
AT (1) ATE128983T1 (fi)
AU (1) AU655858B2 (fi)
CA (1) CA2084431C (fi)
DE (1) DE69205405T2 (fi)
DK (1) DK0549041T3 (fi)
ES (1) ES2081040T3 (fi)
FI (1) FI104178B1 (fi)
GR (1) GR3018630T3 (fi)
HK (1) HK1002033A1 (fi)
MX (1) MX9207394A (fi)
NO (1) NO302525B1 (fi)
NZ (1) NZ245520A (fi)
ZA (1) ZA929315B (fi)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2100514C (en) * 1992-07-29 2005-03-29 Johannes A. M. Hamersma 17-spiromethylene steroids
RU2215540C2 (ru) 1997-11-14 2003-11-10 Акцо Нобель Н.В. Схемы приема гестаген-антигестагена
US6020328A (en) * 1998-03-06 2000-02-01 Research Triangle Institute 20-keto-11β-arylsteroids and their derivatives having agonist or antagonist hormonal properties
EP1079859B1 (en) 1998-05-22 2010-07-14 The Board Of Trustees Of The Leland Stanford Junior University Bifunctional molecules and therapies based thereon
US6262042B1 (en) 1998-05-29 2001-07-17 Research Triangle Institute 17β-amino and hydroxylamino-11β-arylsteroids and their derivatives having agonist or antagonist hormonal properties
US5962444A (en) * 1998-05-29 1999-10-05 Research Triangle Institute 17β-nitro-11β-arylsteroids and their derivatives having agonist or antagonist hormonal properties
RU2234321C2 (ru) * 1999-04-29 2004-08-20 Акцо Нобель Н.В. Применение антипрогестагенов в комбинированной терапии
US6043235A (en) * 1999-07-21 2000-03-28 Research Triangle Institute 11β-aryl-17, 17-spirothiolane-substituted steroids
US7426602B2 (en) * 2004-01-08 2008-09-16 Topside Research, Llc Switch for bus optimization
TW200531977A (en) 2004-03-25 2005-10-01 Akzo Nobel Nv Progesterone receptor modulators
CN103259027A (zh) 2005-04-28 2013-08-21 普罗透斯数字保健公司 药物信息系统
US9062126B2 (en) 2005-09-16 2015-06-23 Raptor Pharmaceuticals Inc. Compositions comprising receptor-associated protein (RAP) variants specific for CR-containing proteins and uses thereof
JP5230449B2 (ja) * 2006-02-17 2013-07-10 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ プロゲステロン受容体モジュレーターとして有用な11−燐ステロイド誘導体
US7671045B2 (en) * 2006-02-17 2010-03-02 Janssen Pharmaceutica N.V. 17-phosphorous steroid derivatives useful as progesterone receptor modulators
BRPI0717747A2 (pt) 2006-10-24 2013-10-22 Repros Therapeutics Inc Composições e métodos de supressão da proliferação endometrial
TWI539953B (zh) 2008-04-28 2016-07-01 瑞波若斯治療學公司 用於治療乳癌之組成物和方法
CN102316902B (zh) 2009-02-20 2014-09-24 to-BBB控股股份有限公司 基于谷胱甘肽的药物递送系统
US8673968B2 (en) * 2009-04-06 2014-03-18 Evestra, Inc. Progesterone antagonists
CN110075069A (zh) 2009-05-06 2019-08-02 实验室护肤股份有限公司 包含活性剂-磷酸钙颗粒复合物的皮肤递送组合物及其应用
CN101926806A (zh) * 2009-06-24 2010-12-29 天津金耀集团有限公司 一种17磷类雌甾化合物在制备紧急避孕药物中的应用
MX2012010327A (es) 2010-03-22 2012-11-16 Repros Therapeutics Inc Composiciones y metodos para la administracion no toxica de antiprogestinas.
WO2011157443A1 (en) 2010-06-17 2011-12-22 N.V. Organon (11b,17a)-11-(4-(2-11c-acetyl)phenyl)-17,23-epoxy-19,24-dinorchola-4,9,20-trien-3-one
US9096641B2 (en) 2013-06-05 2015-08-04 Evestra, Inc. Imidazolyl progesterone antagonists

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3461090D1 (en) * 1983-02-18 1986-12-04 Schering Ag 11-beta-aryl-estradienes, process for their preparation and pharmaceutical compositions containing them
FR2596395B1 (fr) * 1986-03-26 1989-05-26 Roussel Uclaf Nouveaux steroides comportant un cycle spirannique en position 17, leur procede de preparation, leur application comme medicaments et les compositions les renfermant
DE3761308D1 (de) * 1986-07-23 1990-02-08 Akzo Nv 18-phenylestrane-derivate.
IE60780B1 (en) * 1987-01-23 1994-08-10 Akzo Nv New 11-aryl steroid derivatives
EP0289073B1 (en) * 1987-04-24 1991-11-27 Akzo N.V. Novel 11-aryloestrane and 11-arylpregnane derivatives
DE3878198T2 (de) * 1987-12-12 1993-06-24 Akzo Nv 11-arylsteroid-derivate.

Also Published As

Publication number Publication date
DE69205405D1 (de) 1995-11-16
ZA929315B (en) 1993-05-24
DE69205405T2 (de) 1996-05-09
JP3462515B2 (ja) 2003-11-05
ATE128983T1 (de) 1995-10-15
KR100287513B1 (ko) 2001-05-02
EP0549041B1 (en) 1995-10-11
CA2084431A1 (en) 1993-06-21
ES2081040T3 (es) 1996-02-16
FI925790A0 (fi) 1992-12-18
EP0549041A1 (en) 1993-06-30
NO924857D0 (no) 1992-12-15
NO924857L (no) 1993-06-21
FI104178B (fi) 1999-11-30
AU655858B2 (en) 1995-01-12
JPH05255380A (ja) 1993-10-05
US5292878A (en) 1994-03-08
HK1002033A1 (en) 1998-07-24
AU3009392A (en) 1993-06-24
DK0549041T3 (da) 1996-01-29
GR3018630T3 (en) 1996-04-30
FI104178B1 (fi) 1999-11-30
CA2084431C (en) 2003-04-08
MX9207394A (es) 1993-07-30
FI925790L (fi) 1993-06-21
NZ245520A (en) 1995-02-24

Similar Documents

Publication Publication Date Title
NO302525B1 (no) 17-spirofuran-3'-yliden-steroider
FI81588C (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara 11 -fenyl-17-hydroxi-4,9(10)-estradien-3-oner.
US5693628A (en) 11-benzaldoxime-estra-diene derivatives, methods for their production and pharmaceuticals containing these compounds
FI85377B (fi) Foerfarande foer framstaellning av terapeutiskt aktiva 13-alkyl-11 -fenylgonaner.
KR100445376B1 (ko) 11-(치환된페닐)-에스트라-4,9-디엔유도체
FI89054C (fi) Nya 11-arylsteroidderivat
JP2652007B2 (ja) 位置17にスピロ環を有する新規なステロイドの製造用中間体
KR100341169B1 (ko) 17-스피로메틸렌스테로이드
US5728689A (en) 11β-aryl-4-estrenes, process for their production as well as their use as pharmaceutical agents
RU2152952C2 (ru) Производные 11,21-бисфенил-19-норпрегнана, способ их получения, фармацевтическая композиция и способ ее получения
HU196224B (en) Process for production of 19-nor or 19-nor-d-homo stereoids substituated in position 11-beta by alkinylphenil group and medical preparatives containing them as active substance
IE892141L (en) 13-alkyl-11ß-phenylgonanes
RU2187510C2 (ru) Производные 16-гидрокси-11-(замещенный фенил)-эстра-4,9-диена, соединение, фармацевтическая композиция
US5739125A (en) 11 Beta-aryl-gona-4, 9-dien-3-ones
JP5731498B2 (ja) 17−ヒドロキシ−17−ペンタフルオロエチルエステル−4,9(10)−ジエン11−エチニルフェニル誘導体、その製造方法、及び疾病の治療のためのその使用
US5232915A (en) 9α-hydroxy-19,11β-bridged steroids, their production and pharmaceutical preparations containing these steroids
JP3181589B2 (ja) 6、7−変性11β−アリール−4−エステレン
Faraj et al. Synthesis of new steroidal 11β-substituted spirolactones
JPH08502276A (ja) ゲスターゲン作用を有する19,11−架橋した4−エストレン
HU201091B (en) Process for producing gonatriene derivatives and pharmaceutical compositions comprising same
MXPA96003476A (es) Derivados de 11-(fenilo sustituido)-estra-4,9-dieno